Organon (OGN) Equity Ratio (2020 - 2026)

Organon (OGN) has reported Equity Ratio for 7 consecutive years, with 0.07 the latest figure, recorded in Q1 2026.

• In Q1 2026, Equity Ratio rose 68.66% year-over-year to 0.07; the TTM figure through Mar 2026 stood at 0.07 (up 68.66% YoY), while the FY2025 annual figure was 0.06, up 62.22% from the prior year.
• Equity Ratio came in at 0.07 for Q1 2026 at Organon, up from 0.06 in the prior quarter.
• The five-year high for Equity Ratio was 0.07 in Q1 2026, with the low at 0.12 in Q1 2022.
• Average Equity Ratio over 5 years is 0.01, with a median of 0.0 recorded in 2024.
• Across the five-year window, Equity Ratio sank 124.09% in 2022 and jumped 920.59% in 2025, its largest moves.
• Year by year, Equity Ratio stood at 0.08 in 2022, then soared by 92.87% to 0.01 in 2023, then soared by 720.6% to 0.04 in 2024, then soared by 62.22% to 0.06 in 2025, then rose by 18.89% to 0.07 in 2026.
• According to Business Quant data, Equity Ratio over the past three periods registered 0.07, 0.06, and 0.07 for Q1 2026, Q4 2025, and Q3 2025 respectively.